Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cardium, University of Texas Health Science Center deal

The university granted CXM's InnerCool Therapies Inc.

Read the full 79 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE